NCT00516022View on ClinicalTrials.gov

Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.

PHASE2CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

May 31, 2011

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

Mistletoe extract

The drug will be administered 3 times a week at home.

Trial Locations (1)

Unknown

Rambam Medical Center, Haifa

All Listed Sponsors
collaborator

Weleda AG

INDUSTRY

lead

Rambam Health Care Campus

OTHER

NCT00516022 - Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination. | Biotech Hunter | Biotech Hunter